바이오노트: management transactions · South Korea · DART (FSS)

Browse the full directors' dealings record of 바이오노트, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Healthcare sector, 바이오노트 has published 2 public disclosures. Market capitalisation: €509.2bn. The latest transaction was reported on 21 April 2026 (Purchase). Among the most active insiders: 조영식. All data is accessible without an account.